PI: 05 Why is FDA Calling Adequate Provision a "LOOPHOLE"?

The FDA's latest proposal targets what they refer to as the "adequate provision loophole" in advertising, pushing for full disclosure of risk information in TV and radio ads. What does this mean for the future of drug marketing?Application of the final rule could result in a veritable ban on DTC broadcast advertising. Expect longer ads or a shift in advertising strategies, especially towards social media, as companies adapt to these changes. 📺➡️📱Watch the latest episode  @complianceforward  What are your thoughts on this potential shift? Discuss in the comments below.